In addition to its lead program, Biospherics is applying its
expertise in chiral carbohydrate chemistry to create a pipeline of
proprietary candidates across a range of therapeutic indications.
|
|
Clinical TrialsSpherix is currently running a Phase 3 clinical trial to study the use of Naturlose® as a treatment for Type 2 diabetes.
|